The menopur market research report is one of a series of new reports that provides menopur market statistics, including the menopur industry's global market size, regional shares, competitors with a menopur market share, detailed menopur market segments, market trends and opportunities, and any further data you may need to thrive in the menopur industry. This menopur market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The growth in the forecast period can be attributed to increasing prevalence of infertility, growing awareness of assisted reproductive technologies, rising demand for in-vitro fertilization (IVF) treatments, expanding healthcare access, and rising supportive government initiatives for fertility treatments. Major trends in the forecast period include advancements in reproductive medicine, technological advancements in IVF procedures, shift towards personalized fertility treatments, AI-driven personalization of menopur dosage, and integration of AI in treatment planning.
The growing prevalence of infertility is expected to drive the expansion of the menopur market in the coming years. Infertility is defined as the inability to conceive after a year of regular, unprotected intercourse. The rise in infertility rates can be attributed to factors such as lifestyle changes, environmental pollution, and the trend of delayed childbearing. Menopur helps address infertility by stimulating the ovaries to produce multiple eggs, which increases the likelihood of conception. According to the World Health Organization (WHO), approximately 17.5% of the global adult population, or about 1 in 6 individuals, experience infertility each year. This increasing prevalence of infertility is contributing to the growth of the menopur market.
The rise in healthcare spending is also expected to fuel the growth of the menopur market. Healthcare spending refers to the financial resources allocated for healthcare services. This increase in spending is driven by factors such as aging populations, a higher prevalence of chronic diseases, advances in medical technology, and the growing demand for more specialized and personalized care. Menopur plays a role in optimizing healthcare expenditures by offering an effective fertility treatment that may reduce the need for multiple or extended cycles of assisted reproductive technologies, thereby helping to manage treatment costs. For instance, in May 2024, the Office for National Statistics reported that total healthcare expenditure in the UK increased by 5.6% from 2022 to 2023, marking a significant acceleration compared to the 0.9% growth observed in 2022. This increase in healthcare spending is expected to drive growth in the menopur market.
The rising maternal age is also expected to contribute to the growth of the menopur market. Maternal age refers to the age of a woman when she conceives or gives birth, and it has a significant impact on fertility and pregnancy health. The trend of increasing maternal age is largely attributed to factors such as delayed marriage, career advancement, and improvements in fertility treatments that allow women to have children later in life. Menopur is particularly beneficial for women of advanced maternal age, as it helps stimulate the ovaries to produce multiple eggs, thereby improving the chances of conception despite the natural decline in fertility that comes with age. According to the Centers for Disease Control and Prevention (CDC), the average age of mothers at the time of their first birth rose to 27.4 years in 2022, up slightly from 27.3 years in 2021. This trend toward later motherhood is driving the demand for fertility treatments such as menopur.
The key company operating in the menopur market is Ferring Pharmaceuticals.
North America was the largest region in the menopur market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in menopur report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the menopur market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Menopur is a fertility medication that contains human menopausal gonadotropin (hMG), which includes luteinizing hormone (LH) and follicle-stimulating hormone (FSH). It is primarily used to address specific fertility issues in women, particularly those undergoing Assisted Reproductive Technology (ART) procedures, such as in vitro fertilization (IVF). Menopur helps stimulate the development of multiple ovarian follicles, thereby increasing the chances of successful egg retrieval and fertilization.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary indications for menopur are infertility treatment and hypogonadism. Infertility treatment involves medical interventions, therapies, or procedures designed to assist individuals or couples in achieving pregnancy and addressing fertility challenges. Menopur is available in various formulations, including injectable solutions and pre-filled syringes. It is distributed through different channels, such as hospital pharmacies, specialty clinics, retail pharmacies, and online pharmacies. The medication is used by both women and men.
The menopur market consists of sales of menopur injection (hMG), menopur pre-filled syringes and menopur vials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The growth in the forecast period can be attributed to increasing prevalence of infertility, growing awareness of assisted reproductive technologies, rising demand for in-vitro fertilization (IVF) treatments, expanding healthcare access, and rising supportive government initiatives for fertility treatments. Major trends in the forecast period include advancements in reproductive medicine, technological advancements in IVF procedures, shift towards personalized fertility treatments, AI-driven personalization of menopur dosage, and integration of AI in treatment planning.
The growing prevalence of infertility is expected to drive the expansion of the menopur market in the coming years. Infertility is defined as the inability to conceive after a year of regular, unprotected intercourse. The rise in infertility rates can be attributed to factors such as lifestyle changes, environmental pollution, and the trend of delayed childbearing. Menopur helps address infertility by stimulating the ovaries to produce multiple eggs, which increases the likelihood of conception. According to the World Health Organization (WHO), approximately 17.5% of the global adult population, or about 1 in 6 individuals, experience infertility each year. This increasing prevalence of infertility is contributing to the growth of the menopur market.
The rise in healthcare spending is also expected to fuel the growth of the menopur market. Healthcare spending refers to the financial resources allocated for healthcare services. This increase in spending is driven by factors such as aging populations, a higher prevalence of chronic diseases, advances in medical technology, and the growing demand for more specialized and personalized care. Menopur plays a role in optimizing healthcare expenditures by offering an effective fertility treatment that may reduce the need for multiple or extended cycles of assisted reproductive technologies, thereby helping to manage treatment costs. For instance, in May 2024, the Office for National Statistics reported that total healthcare expenditure in the UK increased by 5.6% from 2022 to 2023, marking a significant acceleration compared to the 0.9% growth observed in 2022. This increase in healthcare spending is expected to drive growth in the menopur market.
The rising maternal age is also expected to contribute to the growth of the menopur market. Maternal age refers to the age of a woman when she conceives or gives birth, and it has a significant impact on fertility and pregnancy health. The trend of increasing maternal age is largely attributed to factors such as delayed marriage, career advancement, and improvements in fertility treatments that allow women to have children later in life. Menopur is particularly beneficial for women of advanced maternal age, as it helps stimulate the ovaries to produce multiple eggs, thereby improving the chances of conception despite the natural decline in fertility that comes with age. According to the Centers for Disease Control and Prevention (CDC), the average age of mothers at the time of their first birth rose to 27.4 years in 2022, up slightly from 27.3 years in 2021. This trend toward later motherhood is driving the demand for fertility treatments such as menopur.
The key company operating in the menopur market is Ferring Pharmaceuticals.
North America was the largest region in the menopur market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in menopur report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the menopur market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Menopur is a fertility medication that contains human menopausal gonadotropin (hMG), which includes luteinizing hormone (LH) and follicle-stimulating hormone (FSH). It is primarily used to address specific fertility issues in women, particularly those undergoing Assisted Reproductive Technology (ART) procedures, such as in vitro fertilization (IVF). Menopur helps stimulate the development of multiple ovarian follicles, thereby increasing the chances of successful egg retrieval and fertilization.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary indications for menopur are infertility treatment and hypogonadism. Infertility treatment involves medical interventions, therapies, or procedures designed to assist individuals or couples in achieving pregnancy and addressing fertility challenges. Menopur is available in various formulations, including injectable solutions and pre-filled syringes. It is distributed through different channels, such as hospital pharmacies, specialty clinics, retail pharmacies, and online pharmacies. The medication is used by both women and men.
The menopur market consists of sales of menopur injection (hMG), menopur pre-filled syringes and menopur vials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Menopur Market Characteristics4. Menopur Market Trends And Strategies5. Menopur Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market7. Global Menopur Pricing Analysis & Forecasts30. Global Menopur Market Competitive Benchmarking And Dashboard31. Key Mergers And Acquisitions In The Menopur Market32. Recent Developments In The Menopur Market
3. Menopur Market Biologic Drug Characteristics
6. Global Menopur Growth Analysis And Strategic Analysis Framework
8. Menopur Market Segmentation
9. Global Menopur Epidemiology Of Clinical Indications
10. Menopur Market Regional And Country Analysis
11. Asia-Pacific Menopur Market
12. China Menopur Market
13. India Menopur Market
14. Japan Menopur Market
15. Australia Menopur Market
16. South Korea Menopur Market
17. Western Europe Menopur Market
18. UK Menopur Market
19. Germany Menopur Market
20. France Menopur Market
21. Eastern Europe Menopur Market
22. North America Menopur Market
23. USA Menopur Market
24. Canada Menopur Market
25. South America Menopur Market
26. Middle East Menopur Market
27. Africa Menopur Market
28. Menopur Market Competitive Landscape And Company Profiles
29. Global Menopur Market Pipeline Analysis
33. Menopur Market High Potential Countries, Segments and Strategies
34. Appendix
Executive Summary
Menopur Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on menopur market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for menopur ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The menopur market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Indication: Infertility Treatment; Hypogonadism2) By Formulation: Injectable Solution; Pre-Filled Syringes
3) By Distribution Channel: Hospital Pharmacies; Specialty Clinics; Retail Pharmacies; Online Pharmacies
4) By End User: Women; Men
Key Companies Profiled: Ferring Pharmaceuticals
Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Ferring Pharmaceuticals
